Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. - Wikidata - awgldk - TriplyDB

Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.

Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.

http://www.wikidata.org/entity/Q34662050

about

Dopamine signaling in reward-related behaviors Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens.Dopamine signaling in food addiction: role of dopamine D2 receptors A review of pharmacogenetic studies of substance-related disorders Gene-environment interactions in male reproductive health: special reference to the aryl hydrocarbon receptor signaling pathway Splicing factor transformer-2β (Tra2β) regulates the expression of regulator of G protein signaling 4 (RGS4) gene and is induced by morphine Glial cell line-derived neurotrophic factor (GDNF) as a novel candidate gene of anxiety The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populations Finding the lost treasures in exome sequencing data.ANKK1 and DRD2 pharmacogenetics of disulfiram treatment for cocaine abuse The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction.DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory.Association between secreted phosphoprotein-1 (SPP1) polymorphisms and low bone mineral density in women.MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant Immune-mediated animal models of Tourette syndrome.A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study.Association of dopamine gene variants, emotion dysregulation and ADHD in autism spectrum disorder.Expression of mRNA transcripts encoding membrane transporters detected with whole transcriptome sequencing of human brain and liver Association of mitochondrial DNA polymerase γ gene POLG1 polymorphisms with parkinsonism in Chinese populations.Pharmacogenomic biomarkers: validation needed for both the molecular genetic mechanism and clinical effect.Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans.Specific knockdown of the D2 long dopamine receptor variant.Pharmacogenomics of the RNA world: structural RNA polymorphisms in drug therapy Analyzing allele specific RNA expression using mixture models.Repeat variation in the human PER2 gene as a new genetic marker associated with cocaine addiction and brain dopamine D2 receptor availability.mRNA transcript diversity creates new opportunities for pharmacological intervention.Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system BDNF promoter methylation and genetic variation in late-life depression.Distinct regulation of dopamine D2S and D2L autoreceptor signaling by calcium.Current perspectives on the neurobiology of drug addiction: a focus on genetics and factors regulating gene expression.Network-Dependent Modulation of COMT and DRD2 Polymorphisms in Healthy Young Adults.Common variants in DRD2 are associated with sleep duration: the CARe consortium Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene-gene-environment interaction Genetic influences on nicotinic α5 receptor (CHRNA5) CpG methylation and mRNA expression in brain and adipose tissue.Relationship among methadone dose, polymorphisms of dopamine D2 receptor and tri-dimensional personality questionnaire in heroin-addicted patients HIV-related cognitive impairment shows bi-directional association with dopamine receptor DRD1 and DRD2 polymorphisms in substance-dependent and substance-independent populations.Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction.mRNA changes in nucleus accumbens related to methamphetamine addiction in mice Antisense-mediated RNA targeting: versatile and expedient genetic manipulation in the brain.Genetics of dopamine receptors and drug addiction.

P2860

Q21129462-C037295C-7A02-441F-B718-16B2B0302A75 Q21999524-05529A7A-3D43-475E-A7FF-25C5CAAED6C6 Q27021853-97E65BE0-E0C8-4D8D-89E0-FBEACF6FB8F2 Q27312296-2E6C65C6-F933-4A88-955E-F4CD775063C7 Q28394896-6DF517B4-C3B5-4061-BF04-F155FB56FF8D Q28535422-9D2223AC-4DD8-4DB2-9996-4DB5C342B893 Q28536350-BB6517CB-4156-4E86-B693-ADC6B454BC79 Q30277983-1A1AC10A-13D0-4FBB-9901-853EDA90777E Q30663128-455328DE-3563-4533-936A-2CBAC30C3B5F Q33578546-B4B65EF4-2ADA-460D-8D07-289ADBFB9D3F Q33579769-F65C34B6-65EA-4F0C-B639-ECDE81ACE718 Q33599626-935C248F-C06B-4167-B6DD-4A2C203EE0F5 Q33618811-665D455C-B1E2-45DA-ACBF-683684C69055 Q33676705-B9A7C394-0484-4B2F-903E-8B6C77831CF0 Q33745451-2608B40E-0826-4948-97AC-B82578F58629 Q33838931-8937F923-78C0-4DB2-84B2-99F09929B5AF Q33854534-6A9BFEB7-2D19-44CB-B5D5-DB6A70F63A14 Q34042444-23570ACB-038D-4B02-A746-23A2EBAF8C33 Q34515721-C88E3292-034B-438A-8441-4A6ED9DF4FEA Q35120999-CAF8C33F-2E9A-4071-9BB3-15C713F89767 Q35439069-33410BFE-544E-4C9E-9C7F-609E4832BC2F Q35583316-C816E852-7D28-407D-B6D2-1A659BE2894B Q35654120-C6CC229A-C503-4AEA-BC7C-E2239E26CE4F Q35731672-CA0FEA7B-6FDC-4F4A-961A-8F592D23DD8E Q35844253-8EB2DE2A-E738-4A53-A35E-F199767FDD92 Q35913120-AD3C0FD2-1A57-49EC-BA00-9577D196B585 Q35995415-BF634F2B-550B-41B2-B4B4-3E98EE4B5939 Q36043366-568B2D23-E532-4BB3-94A3-AEF7A1E0CC5E Q36075672-F4571D37-BE46-4FB1-B9C1-3F3D63343A19 Q36337087-09D69AC6-4C26-4DDF-AF94-EB821119E5DC Q36353466-254AA110-56B5-45E4-A4AB-6F0A69D91238 Q36402504-632DAD2E-1572-4243-8CF3-A0391DB1595A Q36593856-2E08345A-38FB-4F5E-9FB4-A2A0365C5B6D Q37030993-312DE5E1-992E-46F0-89DA-A0287156A751 Q37223916-0A1244DE-ABC8-4CB5-927D-A95BD3804AC4 Q37376944-899E715E-9E19-455C-A9EC-1F9718C5F796 Q37401604-9ADCE33D-FD0E-45A9-871F-714CA2E2A6B8 Q37424880-BDBD57B4-2676-4A86-BE70-137619A1EFA5 Q37910743-D14F333D-3556-418D-B97C-ECCAB407FCE0 Q37986616-A3D48D01-D67C-4A56-8FDD-C966B20F143C

P2860

Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.

http://www.wikidata.org/entity/Q34662050

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Intronic polymorphisms affecti ...... associated with cocaine abuse.

@ast

Intronic polymorphisms affecti ...... associated with cocaine abuse.

@en

Intronic polymorphisms affecti ...... associated with cocaine abuse.

@nl

type

label

Intronic polymorphisms affecti ...... associated with cocaine abuse.

@ast

Intronic polymorphisms affecti ...... associated with cocaine abuse.

@en

Intronic polymorphisms affecti ...... associated with cocaine abuse.

@nl

prefLabel

Intronic polymorphisms affecti ...... associated with cocaine abuse.

@ast

Intronic polymorphisms affecti ...... associated with cocaine abuse.

@en

Intronic polymorphisms affecti ...... associated with cocaine abuse.

@nl

P1433

Q34662050-2B463BBE-F60C-4E81-9D3D-7038F95F6FFB

P1476

Q34662050-0F6E63E3-83D7-4D70-B99C-7C6F5D008C26

P2093

Q34662050-01CAABEF-0962-4392-B5F5-1614F2B7FA02

Q34662050-09D45644-6F1A-42B6-978E-60C227B1A8E0

Q34662050-604CD7C8-FEB2-4215-9FAA-A923C2172462

Q34662050-654769DB-7F32-4F47-9D71-63B62F38876F

Q34662050-7D9B4730-70C4-4882-8168-4E9CB7999FF9

Q34662050-E3C182B0-E115-42AD-AA2E-4F301BE474B1

P2860

Q34662050-00E26693-B413-4617-A174-52D0604BBB99

Q34662050-03AA15EC-9F25-4986-A2F8-B17EB746BD7D

Q34662050-0D5C19C7-8F8B-4C0E-8372-23F2481A2F3E

Q34662050-0D6676F5-CAE4-4C5F-B7BB-85A675167144

Q34662050-1102E916-5283-4AE5-BF8D-297CA10FB937

Q34662050-132E6E2D-EC7F-48E5-8F15-E827135EEA2E

Q34662050-132F5883-B675-4484-9B7F-8A1159506B23

Q34662050-1F93A15B-CF18-4FC3-9577-445C25432E1C

Q34662050-2544F30F-51D4-4889-9667-0A52B47186D1

Q34662050-265A436D-3A9E-4E9C-9D23-800DA7C069F8

P2888

Q34662050-10723347-88FF-437C-AE6D-27206D7199A2

P304

Q34662050-012DE93C-C64D-4296-9B7A-0DCE1034F8B8

P31

Q34662050-CC0C8633-4E80-4FF3-B77F-34E7D365E8D1

P356

Q34662050-CAF76ED0-6642-42C5-B395-58C7324CE518

P407

Q34662050-51448AC8-27E9-4FDE-9F95-5436D859E7D7

P433

Q34662050-E3ABCE81-68E1-4D70-B7A7-18100955480C

P478

Q34662050-3DA94A06-577F-4F9B-9171-22011B2C62A2

P50

Q34662050-C2F15185-A9DB-4EDC-88CF-5165A49F746C

P577

Q34662050-92365C71-BB7C-4165-A830-ED1F344734A2

P5875

Q34662050-ABF7C10F-F5A1-4F75-81A5-6DAFAE0D50F3

P6179

Q34662050-BD0B8737-609C-4222-B688-AF3CD3570BAF

P698

Q34662050-70126C17-C43E-443C-BD3F-E81878FCCDAA

P921

Q34662050-0d91d7c0-1323-4fcc-84ce-a55f2235ade9

P932

Q34662050-D634DC8A-F63C-4B7F-A5FB-092745E44301

P356

P1433

Neuropsychopharmacology

P1476

Intronic polymorphisms affecti ...... associated with cocaine abuse.

@en

P2093

Audrey C Papp

http://www.w3.org/2001/XMLSchema#string

Danxin Wang

http://www.w3.org/2001/XMLSchema#string

Deborah C Mash

http://www.w3.org/2001/XMLSchema#string

Linda Duque

http://www.w3.org/2001/XMLSchema#string

Robert A Moyer

http://www.w3.org/2001/XMLSchema#string

Ryan M Smith

http://www.w3.org/2001/XMLSchema#string

P2860

NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory

A second generation human haplotype map of over 3.1 million SNPs

Distinct functions of the two isoforms of dopamine D2 receptors

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

The evolutionary significance of cis-regulatory mutations

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions

Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice

Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning

SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap

P2888

P304

753-762

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2010.208

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49676684

http://www.w3.org/2001/XMLSchema#string

P6179

1034416034

http://www.w3.org/2001/XMLSchema#string

P698

21150907

http://www.w3.org/2001/XMLSchema#string

P921

P932

3055737

http://www.w3.org/2001/XMLSchema#string